News:

  3. Paxlovid may better cut risk of severe COVID outcomes in asthma patients than molnupiravir
+-+-

User+-

Welcome, Guest.
Please login or register.
 
 
 
Forgot your password?
« previous next »
Pages: [1]

Author Topic: Paxlovid may better cut risk of severe COVID outcomes in asthma patients than molnupiravir  (Read 1179 times)

0 Members and 0 Guests are viewing this topic.

Paxlovid may better cut risk of severe COVID outcomes in asthma patients than molnupiravir
« on: »
Paxlovid may better cut risk of severe COVID outcomes in asthma patients than molnupiravir.

This study was published on March 3, 2025

Source of information.

1. CIDRAP.

https://www.cidrap.umn.edu/covid-19/paxlovid-may-better-cut-risk-severe-covid-outcomes-asthma-patients-molnupiravir
Logged

Share on Bluesky Share on Facebook

Pages: [1]
« previous next »
  3. Paxlovid may better cut risk of severe COVID outcomes in asthma patients than molnupiravir